Results 51 to 60 of about 13,502 (225)
HemaSphere, Volume 10, Issue 4, April 2026.Abstract Neurotoxicity is a common and potentially life‐threatening complication after chimeric antigen receptor T‐cell therapy (CART) for pediatric B‐cell acute lymphoblastic leukemia (B‐ALL). The only consistently demonstrated clinical risk factor for severe neurotoxicity in prior studies is high, preinfusion bone marrow disease burden (DB).
Caroline Diorio +18 more
wiley +1 more source
Hematology, Transfusion and Cell TherapyIntrodução: O contexto oncológico traz a necessidade de uma assistência multiprofissional e diversas intervenções de cuidado em toda a jornada de tratamento, Esta jornada,em específico do câncer no sangue, afeta as bases de segurança.
LT Ferri, RC Pires
doaj +1 more source
Malignancies in adult patients with common variable immunodeficiency
Revista Alergia México, 2015 Background: Common variable immunodeficiency (CVID) implies an increased risk of cancer, with an estimated incidence of 11-13%, particularly during the 5th and 6th decade of life.
Eunice Giselle López-Rocha +3 more
doaj +1 more source
Revista Paraguaya de Reumatología, 2023 La presencia de linfadenopatías generalizadas se ha asociado de forma usual con lupus eritematoso sistémico (LES), sin embargo, no es usual encontrar este hallazgo como manifestación inicial de la enfermedad.
María Raad Sarabia +6 more
doaj +1 more source
Revista de Educação Continuada em Medicina Veterinária e Zootecnia do CRMV-SP, 1999 Apresentam-se neste artigo de revisão, informações básicas sobre linfomas caninos. Descrevem-se, sucintamente, definição, incidência, etiologia, sinais clínicos, estadiamento, classificação morfológica e imunofenotípica, diagnóstico e prognóstico.
Veridiana Maria Brianezi Diagnani De Moura +2 more
openaire +2 more sources
Shared Decision‐Making in Treatment Selection in Multiple Myeloma in Spain: The PRISMMA Study
European Journal of Haematology, Volume 116, Issue 2, Page 185-194, February 2026.ABSTRACT Introduction Perceptions and experiences of shared decision‐making between patients and physicians in multiple myeloma (MM) care are not fully understood. A survey study was conducted to explore these perspectives in Spain. Methods Two anonymous online surveys, one for haematologists and one for MM patients, were developed.
Valentín Cabañas +5 more
wiley +1 more source
Biomédica: revista del Instituto Nacional de Salud, 2022 Introducción. El consorcio europeo BIOMED-2 se creó para determinar si una población linfoide de difícil clasificación patológica es clonal. En Colombia, la implementación de estas pruebas comenzó en el 2015 en el Instituto Nacional de Cancerología E.S.E.
Nicolás Villamizar-Rivera +1 more
doaj +1 more source
Epigenetic reprogramming in multiple myeloma—Challenges and opportunities
International Journal of Cancer, Volume 158, Issue 2, Page 423-432, 15 January 2026.Abstract In cancer, mutational processes act in concert with epigenetic reprogramming to endow malignant cells with hallmark properties that underpin tumorigenesis. Compared with the relatively rigid and slow processes of genetic evolution, the plastic nature of chromatin enables cells to adapt to a changing environment more rapidly.
Subhasree Kumar +2 more
wiley +1 more source
Hematology, Transfusion and Cell TherapyIntrodução: O vírus da imunodeficiência humana (HIV) é carcinogênico em humanos, tanto por ação viral direta quanto por imunossupressão, desregulação imune e estimulação antigênica crônica, o que favorece o desenvolvimento de neoplasias.
Mario Gustavo de Aranda PACHECO +7 more
doaj +1 more source